Improving Engagement From Underserved Communities With Prostate Cancer Genetics Services

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexMale
Age18+
SponsorRoyal Marsden NHS Foundation Trust

About this trial

Earlier work explored barriers and facilitators to accessing prostate cancer screening, particularly in underserved communities, and provided valuable insights to build upon.

This study will explore perspectives on how genetic risk for prostate cancer is explained and understood through in-depth interviews with members of underserved communities. Findings from this work, alongside earlier results, will be used to co-design clear and accessible digital educational resources in collaboration with community members and relevant charities.

Participation in cancer screening programmes in the UK varies, with differences linked to socioeconomic status, ethnicity and health literacy. Similar inequalities are seen in access to prostate cancer genetics services, indicating a need for improved engagement.

Successful integration of genetics into prostate cancer care requires clear and inclusive information about genetic testing processes, possible outcomes and interpretation of results. Currently, there are limited resources explaining genetic risk for prostate cancer in an accessible way.

Co-production with representatives from underserved communities will ensure that educational materials are understandable, relevant and acceptable to all.

Eligibility criteria

Qualifiers

Men and people with prostates age 18 and above

Those who belong to the three underserved groups; Black African and Black Caribbean Ancestry, transgender and non-binary people with a prostate and those with reduced access to healthcare

We allow intersectionality within reason and will narratively describe any instances of these in the writeup of findings

Those who are able to freely consent to inclusion

Disqualifiers

To avoid exhaustion, we will only allow participation in two interview or focus groups per individual for the entirety of the study

Those without capacity to consent to interview (capacity is assumed unless there is good reason to believe otherwise)

Trial design

Treatments tested in this trial

  • Surveys
  • Semi-structured interviews and focus groups

Treatment groups

100 Participants
are divided into 1 treatment group

Locations

This trial has no locations